Great Point Partners LLC Portfolio Holdings
Great Point Partners LLC
- $216 Million
- Q3 2024
Great Point Partners LLC has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $216 Million distributed in 30 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Pliant Therapeutics, Inc. with a value of $21.4M, Evolus, Inc. with a value of $19M, Viridian Therapeutics, Inc.\De with a value of $17.1M, Cytokinetics Inc with a value of $16.7M, and Kal Vista Pharmaceuticals, Inc. with a value of $15M.
Examining the 13F form we can see an decrease of $161M in the current position value, from $377M to 216M.
Great Point Partners LLC is based out at Greenwich, CT
Below you can find more details about Great Point Partners LLC portfolio as well as his latest detailed transactions.